medinova lakeside clinical research limited
medinova lakeside clinical research limited Company Information
Company Number
11015310
Registered Address
500 south oak way green park, reading, RG2 6AD
Industry
Other human health activities
Telephone
-
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
accellacare uk limited 100%
medinova lakeside clinical research limited Estimated Valuation
Pomanda estimates the enterprise value of MEDINOVA LAKESIDE CLINICAL RESEARCH LIMITED at £0 based on a Turnover of £0 and 0.58x industry multiple (adjusted for size and gross margin).
medinova lakeside clinical research limited Estimated Valuation
Pomanda estimates the enterprise value of MEDINOVA LAKESIDE CLINICAL RESEARCH LIMITED at £0 based on an EBITDA of £-3.4k and a 4.83x industry multiple (adjusted for size and gross margin).
medinova lakeside clinical research limited Estimated Valuation
Pomanda estimates the enterprise value of MEDINOVA LAKESIDE CLINICAL RESEARCH LIMITED at £0 based on Net Assets of £-52.5k and 2.48x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Medinova Lakeside Clinical Research Limited Overview
Medinova Lakeside Clinical Research Limited is a live company located in reading, RG2 6AD with a Companies House number of 11015310. It operates in the other human health activities sector, SIC Code 86900. Founded in October 2017, it's largest shareholder is accellacare uk limited with a 100% stake. Medinova Lakeside Clinical Research Limited is a young, unknown sized company, Pomanda has estimated its turnover at £0 with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Medinova Lakeside Clinical Research Limited Health Check
There is insufficient data available to calculate a health check for Medinova Lakeside Clinical Research Limited. Company Health Check FAQs
0 Strong
0 Regular
4 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Medinova Lakeside Clinical Research Limited
- - Industry AVG
Growth
3 year (CAGR) sales growth of -100%, show it is growing at a slower rate (4.7%)
- Medinova Lakeside Clinical Research Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Medinova Lakeside Clinical Research Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Medinova Lakeside Clinical Research Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (20)
- Medinova Lakeside Clinical Research Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Medinova Lakeside Clinical Research Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Medinova Lakeside Clinical Research Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Medinova Lakeside Clinical Research Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Medinova Lakeside Clinical Research Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Medinova Lakeside Clinical Research Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 27 weeks, this is less cash available to meet short term requirements (107 weeks)
- - Medinova Lakeside Clinical Research Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 168%, this is a higher level of debt than the average (26.4%)
- - Medinova Lakeside Clinical Research Limited
- - Industry AVG
MEDINOVA LAKESIDE CLINICAL RESEARCH LIMITED financials
Medinova Lakeside Clinical Research Limited's latest turnover from December 2022 is 0 and the company has net assets of -£52.5 thousand. According to their latest financial statements, we estimate that Medinova Lakeside Clinical Research Limited has 1 employee and maintains cash reserves of £68.3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Mar 2020 | Mar 2019 | Mar 2018 | |
|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | 83,229 | 1,577,022 | ||
| Other Income Or Grants | 0 | 0 | ||||
| Cost Of Sales | -8,233 | 362,464 | 25,983 | |||
| Gross Profit | 91,462 | 1,214,558 | ||||
| Admin Expenses | 130,556 | 897,244 | ||||
| Operating Profit | -5,833 | -5,843 | -39,094 | 317,314 | ||
| Interest Payable | 256 | 328 | 257 | 115 | ||
| Interest Receivable | 0 | 0 | 0 | 0 | ||
| Pre-Tax Profit | -6,089 | -6,171 | -39,351 | 317,199 | ||
| Tax | 0 | 0 | 0 | 0 | ||
| Profit After Tax | -6,089 | -6,171 | -39,351 | 317,199 | ||
| Dividends Paid | 0 | 0 | 0 | 0 | ||
| Retained Profit | -6,089 | -6,171 | -39,351 | 317,199 | ||
| Employee Costs | 0 | 0 | ||||
| Number Of Employees | ||||||
| EBITDA* | -3,401 | -3,281 | -36,102 | 318,951 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Mar 2020 | Mar 2019 | Mar 2018 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 8,008 | 10,440 | 16,349 | 19,341 | 20,979 | 14,984 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 8,008 | 10,440 | 16,349 | 19,341 | 20,979 | 14,984 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 33,669 | 0 | 0 |
| Misc Debtors | 1,000 | 501 | 9,250 | 13,191 | 8,989 | 27,048 |
| Cash | 68,256 | 26,512 | 29,774 | 14,627 | 4,652 | 49 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 69,256 | 27,013 | 39,024 | 61,487 | 13,641 | 27,097 |
| total assets | 77,264 | 37,453 | 55,373 | 80,828 | 34,620 | 42,081 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 19,767 | 61,345 | 90,395 |
| Group/Directors Accounts | 128,906 | 83,906 | 35,330 | 0 | 284,273 | 3,456 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 900 | 0 | 60,325 | 61,992 | 7,132 | 4,000 |
| total current liabilities | 129,806 | 83,906 | 95,655 | 81,759 | 352,750 | 97,851 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 129,806 | 83,906 | 95,655 | 81,759 | 352,750 | 97,851 |
| net assets | -52,542 | -46,453 | -40,282 | -931 | -318,130 | -55,770 |
| total shareholders funds | -52,542 | -46,453 | -40,282 | -931 | -318,130 | -55,770 |
| Dec 2022 | Dec 2021 | Dec 2020 | Mar 2020 | Mar 2019 | Mar 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | -5,833 | -5,843 | -39,094 | 317,314 | ||
| Depreciation | 2,432 | 2,562 | 2,992 | 1,637 | 5,435 | 999 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | ||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 499 | -8,749 | 261 | 37,871 | -18,059 | 27,048 |
| Creditors | 0 | 0 | -61,345 | -41,578 | -29,050 | 90,395 |
| Accruals and Deferred Income | 900 | -60,325 | 53,193 | 54,860 | 3,132 | 4,000 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -3,000 | -54,857 | -44,515 | 294,362 | ||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 45,000 | 48,576 | -248,943 | -284,273 | 280,817 | 3,456 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||
| interest | -256 | -328 | -257 | -115 | ||
| cash flow from financing | 44,744 | 48,248 | 67,999 | -284,388 | ||
| cash and cash equivalents | ||||||
| cash | 41,744 | -3,262 | 25,122 | 9,975 | 4,603 | 49 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 41,744 | -3,262 | 25,122 | 9,975 | 4,603 | 49 |
medinova lakeside clinical research limited Credit Report and Business Information
Medinova Lakeside Clinical Research Limited Competitor Analysis
Perform a competitor analysis for medinova lakeside clinical research limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other young companies, companies in RG2 area or any other competitors across 12 key performance metrics.
medinova lakeside clinical research limited Ownership
MEDINOVA LAKESIDE CLINICAL RESEARCH LIMITED group structure
Medinova Lakeside Clinical Research Limited has no subsidiary companies.
Ultimate parent company
ICON INVESTMENTS LTD
#0120551
2 parents
MEDINOVA LAKESIDE CLINICAL RESEARCH LIMITED
11015310
medinova lakeside clinical research limited directors
Medinova Lakeside Clinical Research Limited currently has 4 directors. The longest serving directors include Mr Paul Talini (May 2019) and Mr Paul Talini (May 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Paul Talini | England | 39 years | May 2019 | - | Director |
| Mr Paul Talini | England | 39 years | May 2019 | - | Director |
| Mr Brendan Harte | United Kingdom | 59 years | Aug 2019 | - | Director |
| Ms Emer Lyons | England | 46 years | Oct 2023 | - | Director |
P&L
December 2022turnover
0
0%
operating profit
-5.8k
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
-52.5k
+0.13%
total assets
77.3k
+1.06%
cash
68.3k
+1.57%
net assets
Total assets minus all liabilities
Similar Companies
medinova lakeside clinical research limited company details
company number
11015310
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
October 2017
age
7
accounts
Full Accounts
ultimate parent company
previous names
N/A
incorporated
UK
address
500 south oak way green park, reading, RG2 6AD
last accounts submitted
December 2022
medinova lakeside clinical research limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to medinova lakeside clinical research limited.
medinova lakeside clinical research limited Companies House Filings - See Documents
| date | description | view/download |
|---|
